Tapenta is indicated for relief of moderate to severe pain associated with cancer. It has been available in Japan from August 2014. The tablet is approved by more than 40 countries and is approved as tamper-resistant in Japan.

Source: The Nation Bangkok July 27, 2017 14:48 UTC